My two cents worth....
I have been in this thing since March 2005. Given the track record since then, this "sale" is nothing more than a spin-off of the name "Medify" (as I there can be no other assets to send with it per the last PTEL balance sheet), in which PTEL will retain 20% of the shares, give the three or less people that will "run" the new Medify entity some shares, and float the rest on pink sheets. There is no actual sale here in the traditional sense, in my opinion.